Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice

This publication has 54 references indexed in Scilit:

• The immunology of susceptibility and resistance to Leishmania major in mice
  Nature Reviews Immunology, 2002
• The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure
  The Journal of Experimental Medicine, 2001
• Parasite dose determines the Th1/Th2 nature of the response toLeishmania major independently of infection route and strain of host or parasite
  European Journal of Immunology, 1998
• Necrotizing and suppurative lymphadenitis in Leishmania major infections
  Tropical Medicine & International Health, 1996
• Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis Infection
  Immunity, 1996
• The Regulation of Immunity to Leishmania Major
  Annual Review of Immunology, 1995
• Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
  The Journal of Experimental Medicine, 1993
• Recombinant interleukin 12 cures mice infected with Leishmania major.
  The Journal of Experimental Medicine, 1993
• Establishment of Stable, Cell-Mediated Immunity that Makes "Susceptible" Mice Resistant to Leishmania major
  Science, 1992
• Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
  The Journal of Experimental Medicine, 1989